Friday, January 20, 2017

The Longest-Running Musical in Broadway History

 

An associate professor of dermatology at Harvard Medical School, Sam W. Lee is an avid supporter of the arts. Sam W. Lee is particularly fond of traveling to New York City with his family and attending Broadway shows.

No Broadway musical has matched the longevity of Andrew Lloyd Webber’s The Phantom of the Opera. In 2006, the production overtook Cats as the longest-running show in Broadway history, with 7,486 performances. That show count has since surpassed 12,000.

In London, The Phantom of the Opera ran at Her Majesty’s Theater for more than three decades, logging an additional 12,000 performances. On Broadway, the 1996 revival of Chicago has run for more than 8,000 performances, second to Phantom by nearly 4,000 shows.

Andrew Lloyd Webber’s The Phantom of the Opera has won more than 70 major honors and awards, including a Tony Award for Best Musical, six additional Tony Awards, seven Drama Desk Awards, and three Olivier Awards in the UK.

Tuesday, January 10, 2017

DF/HCC’s Cancer Care Delivery Research Program

 

Associate Professor Sam W. Lee teaches courses on dermatology at Harvard Medical School in Boston, Massachusetts. Sam W. Lee also serves as a full member of Dana-Farber/Harvard Cancer Center (DF/HCC), which pools together resources of the university’s cancer research community.

At the core of DF/HCC’s work are some of Boston’s medical facilities, namely Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and the Massachusetts General Hospital. The Harvard Medical School and the Harvard T.H. Chan School of Public Health also form part of this comprehensive cancer center. Together with over 1,100 researchers, DF/HCC leads innovative cancer research programs.

DF/HCC heads 18 clinical-based or discipline-based research programs. The Cancer Care Delivery Research Program, a discipline-based program, seeks to improve cancer care by creating cost-effective interventions. It also focuses on eliminating socioeconomic disparities which affect the delivery of cancer treatment. With over 50 investigators, the Cancer Care Delivery Research Program works to ensure the implementation of quality cancer care.